World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
26861
World Ranking
9434
National Ranking
4866

Judith E. Karp publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Judith E. Karp sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 396 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Judith E. Karp D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Judith E. Karp sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Judith E. Karp is affiliated with Johns Hopkins University in the United States and has contributed extensively to the field of medicine, with a particular focus on hematology. Their research spans several subfields including hematology, genetics, molecular biology, oncology, and public health, environmental and occupational health.

The researcher's primary areas of study include acute myeloid leukemia, myeloproliferative neoplasms, chronic myeloid leukemia treatments, histone deacetylase inhibitors, multiple myeloma, protein degradation, inhibitors, and ethics in clinical research.

Judith E. Karp's recent publications include:

  • Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse? (2020, Leukemia)
  • Advances in therapeutic options for newly diagnosed, high-risk AML patients (2021, Therapeutic Advances in Hematology)
  • Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome (2021, Bone Marrow Transplantation)
  • Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia (2021, Hematological Oncology)
  • The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication? (2021, eJHaem)

The scientist has frequently published in several venues, including:

  • Leukemia
  • Leukemia Research
  • UNC Libraries
  • Therapeutic Advances in Hematology
  • Bone Marrow Transplantation

Judith E. Karp has collaborated regularly with various co-authors, notably including Catherine Lai, Amy E. DeZern, Amanda L. Blackford, B. Douglas Smith, and Elihu H. Estey.

Best Publications

  • Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

    John R. Wingard;William G. Merz;Michael G. Rinaldi;Thomas R. Johnson

  • Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA

    Wenqiang Yu;David Gius;Patrick Onyango;Kristi Muldoon-Jacobs

  • Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

    Joshua Wechsler;Marianne Greene;Michael A. McDevitt;John Anastasi

  • Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.

    Judith E. Karp;Jeffrey E. Lancet;Scott H. Kaufmann;David W. End

  • Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

    Steven D. Gore;Stephen Baylin;Elizabeth Sugar;Hetty E. Carraway

  • Potential Role of Tamoxifen in Prevention of Breast Cancer

    Susan G. Nayfield;Judith E. Karp;Leslie G. Ford;F. Andrew Dorr

  • Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide

    Andrew M. Yeager;Herbert Kaizer;George W. Santos;Rein Saral

  • Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.

    J R Wingard;W G Merz;M G Rinaldi;C B Miller

  • Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse

    Scott H. Kaufmann;Judith E. Karp;Phyllis A. Svingen;Stan Krajewski

  • From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus Panel

    Philip A. Pizzo;Donald Armstrong;Gerald Bodey;Ben de Pauw

  • Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias

    Ivana Gojo;Anchalee Jiemjit;Jane B. Trepel;Alex Sparreboom

  • Expression of breast cancer resistance protein in blast cells from patients with acute leukemia

    Douglas D. Ross;Judith E. Karp;Tar T. Chen;L. Austin Doyle

  • Prevention and treatment of cancer-related infections

    Lindsey Robert Baden;William Bensinger;Michael Angarone;Corey Casper

  • Oral Norfloxacin for Prevention of Gram-Negative Bacterial Infections in Patients with Acute Leukemia and Granulocytopenia: A Randomized, Double-Blind, Placebo-Controlled Trial

    Judith E. Karp;William G. Merz;Carol Hendricksen;Barbara Laughon

  • SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes

    Francis J. Giles;Alison T. Stopeck;Lewis R. Silverman;Jeffrey E. Lancet

  • A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.

    Jonathan M. Gerber;B. Douglas Smith;Brownhilda Ngwang;Hao Zhang

  • Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

    Eric K. Rowinsky;Philip J. Burke;Judith E. Karp;Robert W. Tucker

  • Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors

    Mark Levis;Patrick Brown;B. Douglas Smith;Adam Stine

  • Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

    Judith E. Karp;James D. Dick;Chris Angelopulos;Patricia Charache

  • Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10)

    Robert B. Geller;Marianna Zahurak;Craig A. Hurwitz;Philip J. Burke

Frequent Co-Authors

B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Mark J. Levis
Mark J. Levis Johns Hopkins University
Michael A. McDevitt
Michael A. McDevitt Johns Hopkins University
John J. Wright
John J. Wright National Institutes of Health
James G. Herman
James G. Herman University of Pittsburgh
Richard J. Jones
Richard J. Jones Johns Hopkins University
Allan D. Hess
Allan D. Hess Johns Hopkins University
William G. Merz
William G. Merz Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online medical and healthcare degrees can offer greater flexibility and a more affordable way to start or advance your career in the medical field. Many students look for the phd in nursing online programs to pursue advanced research or leadership roles without stepping away from their current responsibilities.

If you’re already an RN, consider the most affordable accredited online rn to bsn programs to boost your qualifications and open up further career opportunities. For those with a non-nursing background, accelerated options such as direct entry msn programs for non nurses online provide a direct path into nursing with less time commitment.

Admission to medical and nursing schools in the US can be highly competitive, but there are accessible options out there. Researching the easiest nursing programs to get into might help you find a school that matches your academic profile and career goals.

Whether you choose to study online or on campus, these pathways allow you to begin or advance your healthcare career at your own pace while balancing your personal and professional life.

Best Scientists Citing Judith E. Karp

Trending Scientists

Recently Published Articles